Patents by Inventor Michael H. Cain

Michael H. Cain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6103911
    Abstract: The present invention relates to a process for the reduction of an azetidinone-carboxylic acid to an azetidine-alcohol.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: August 15, 2000
    Assignee: Abbott Laboratories
    Inventors: James E. Resek, Shyamal I. Parekh, Pulla R. Singam, Hemant H. Patel, Michael H. Cain, Bikshandarkoil A. Narayanan
  • Patent number: 5958951
    Abstract: The present invention provides R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride in its pure and stable anhydrous form.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: September 28, 1999
    Assignee: Novo Nordiskials
    Inventors: Preben Ahrndt, Henning B.o slashed.rge Petersen, Vincent H. Chang, Kimberly Ann Allen, Michael H. Cain
  • Patent number: 4508718
    Abstract: Cardiotonic and antihypertensive imidazole or triazole substituted phenyl-4H-1,3,4-oxadiazin-5(6H)-ones are described including pharmaceutical compositions and methods of administering the active ingredients. The subject compounds may be manufactured by ring closing appropriate derivatives of benzoic acid-2-(haloacetyl)hydrazides with sodium hydride.
    Type: Grant
    Filed: January 16, 1984
    Date of Patent: April 2, 1985
    Assignee: Warner-Lambert Company
    Inventors: Ila Sircar, Michael H. Cain, John G. Topliss